Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

L.A. McKeown

December 08, 2023

Presentation AHA 2023

Validation of a Speech Analysis Application to Detect Worsening Heart Failure Events in Ambulatory Heart Failure Patients

Presenter: William T. Abraham

November 15, 2023

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Conference News HFSA 2023

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

L.A. McKeown

October 18, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Todd Neale

September 13, 2023

News Conference News ESC 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

L.A. McKeown

September 01, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

Shelley Wood

August 25, 2023

News Opinion CV Team Dispatch

August 2023 News Roundup

L.A. McKeown

August 01, 2023

News Opinion CV Team Dispatch

July 2023 News Roundup

L.A. McKeown

July 01, 2023

News Daily News

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

Shelley Wood

May 30, 2023

News Opinion CV Team Dispatch

May 2023 News Roundup

L.A. McKeown

May 01, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

AHA/ACC Scientific Statement Supports Exercise Therapy in HFpEF

L.A. McKeown

March 27, 2023

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

L.A. McKeown

February 08, 2023

Advertisement

AHA Selects 2023’s Leading Cardiovascular Research

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

Validation of a Speech Analysis Application to Detect Worsening Heart Failure Events in Ambulatory Heart Failure Patients

November 2023 News Roundup

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

October 2023 News Roundup

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

September 2023 News Roundup

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

August 2023 News Roundup

July 2023 News Roundup

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

May 2023 News Roundup

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

AHA/ACC Scientific Statement Supports Exercise Therapy in HFpEF

Vast Majority of HFrEF Patients Eligible for Vericiguat

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content